NCT01433185

Brief Summary

Early accurate diagnosis is one of the first crucial steps in care for infants born to HIV-infected mothers. Early initiation of antiretroviral therapy (ART) relies upon early diagnosis and results in significant reductions in infant morbidity and mortality. There is little information on evidence-based interventions that specifically target improved attendance of postpartum clinic visits and subsequent infant HIV testing in the context of prevention of mother-to-child transmission of HIV (PMTCT) programs. The investigators propose a randomized controlled trial to examine the effect of text messages sent to women enrolled in PMTCT programs on adherence to postpartum clinic visits and uptake of early infant diagnosis by DNA polymerase chain reaction (PCR). This study seeks to test the hypotheses that (a) text messages sent to women enrolled in PMTCT will improve their attendance at the postnatal clinic within the first 6-8 weeks after childbirth; and (b) text messages sent to women enrolled in PMTCT programs will increase uptake of DNA PCR HIV testing at 6-8 weeks among infants exposed to HIV. This study will evaluate a novel strategy to improve adherence to postnatal clinic visits and increase the uptake of infant HIV testing. If proven superior to standard care, the proposed intervention can be easily scaled-up and integrated into existing healthcare systems in resource-limited settings. Findings from this study will provide randomized trial evidence to inform HIV prevention program planners and implementers. This study will also provide further information on the feasibility of using mobile phone-based technology for public health interventions in resource-limited settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
388

participants targeted

Target at P50-P75 for not_applicable hiv-infections

Timeline
Completed

Started Apr 2012

Shorter than P25 for not_applicable hiv-infections

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 13, 2011

Completed
7 months until next milestone

Study Start

First participant enrolled

April 1, 2012

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

January 21, 2015

Status Verified

January 1, 2015

Enrollment Period

1.2 years

First QC Date

September 12, 2011

Last Update Submit

January 19, 2015

Conditions

Keywords

PMTCTSMSHIV InfectionsAcquired Immunodeficiency SyndromePrevention & ControlPatient ComplianceCellular PhoneRandomized Controlled Trial

Outcome Measures

Primary Outcomes (2)

  • Proportion of women who attend postnatal clinic within 6-8 weeks postpartum

    6-8 weeks after delivery

  • Proportion of infants tested for HIV by DNA PCR

    6-8 weeks after delivery

Secondary Outcomes (3)

  • Infant adherence to antiretroviral prophylaxis

    Up to 6 weeks after delivery

  • Time to post-natal clinic return

    Up to 8 weeks after delivery

  • Maternal adherence to antiretroviral prophylaxis

    Up to 8 weeks after delivery

Study Arms (2)

Text message (SMS)

EXPERIMENTAL

Text messages sent to women before and after delivery

Other: Text message

Usual care (current standard of care)

NO INTERVENTION

Current standard of care for women enrolled in PMTCT programs

Interventions

Text messages sent to women before and after delivery

Also known as: SMS, short message service, text messaging
Text message (SMS)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age at least 18 years
  • report ability to read SMS
  • ≥ 28 weeks gestation or delivery at study clinic on day of enrollment
  • HIV positive women enrolled in the PMTCT program
  • have access to a mobile phone (personal or partner's if HIV serostatus disclosed to partner)
  • willing to receive SMS messages from the study
  • planning to remain in the study area (Nyanza province) for the duration of the study

You may not qualify if:

  • age less than 18 years old
  • women who share phones with partners but HIV status not disclosed to partners
  • intention to deliver at a non-study hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kenya Medical Research Institute, Family AIDS Care and Education Services

Kisumu, Nyanza, Kenya

Location

Related Publications (2)

  • Odeny TA, Bukusi EA, Cohen CR, Yuhas K, Camlin CS, McClelland RS. Texting improves testing: a randomized trial of two-way SMS to increase postpartum prevention of mother-to-child transmission retention and infant HIV testing. AIDS. 2014 Sep 24;28(15):2307-12. doi: 10.1097/QAD.0000000000000409.

  • Odeny TA, Newman M, Bukusi EA, McClelland RS, Cohen CR, Camlin CS. Developing content for a mHealth intervention to promote postpartum retention in prevention of mother-to-child HIV transmission programs and early infant diagnosis of HIV: a qualitative study. PLoS One. 2014 Sep 2;9(9):e106383. doi: 10.1371/journal.pone.0106383. eCollection 2014.

MeSH Terms

Conditions

HIV InfectionsAcquired Immunodeficiency SyndromePatient Compliance

Interventions

Spermine Synthase

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesSlow Virus DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Alkyl and Aryl TransferasesTransferasesEnzymesEnzymes and Coenzymes

Study Officials

  • Thomas A Odeny, MBChB, MPH

    University of Washington/Kenya Medical Research Institute

    PRINCIPAL INVESTIGATOR
  • R Scott McClelland, MD, MPH

    University of Washington

    STUDY CHAIR
  • Craig R Cohen, MD, MPH

    University of California, San Francisco

    STUDY CHAIR
  • Carol Camlin, PhD

    University of California, San Francisco

    STUDY CHAIR
  • Elizabeth A Bukusi, MBChB, MMed, MPH, PhD

    Kenya Medical Research Institute

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 12, 2011

First Posted

September 13, 2011

Study Start

April 1, 2012

Primary Completion

July 1, 2013

Study Completion

July 1, 2013

Last Updated

January 21, 2015

Record last verified: 2015-01

Locations